Slayback Pharma

About

Slayback Pharma LLC is a specialty pharmaceutical company based in Princeton, New Jersey, founded in 2011 by Ajay Singh. The company specializes in the development, manufacturing, and sourcing of complex generic and specialty pharmaceutical products, particularly focusing on complex injectables and non-solid oral medications. With a workforce of approximately 55 employees, Slayback reported revenue of $17.3 million and has secured $170 million in funding. As a wholly-owned subsidiary of Azurity Pharmaceuticals, Slayback enhances its research and development capabilities and expands its pipeline for innovative drug formulations. The company offers a range of complex generic pharmaceuticals and emphasizes drug development and manufacturing that addresses unmet medical needs. Its product portfolio includes areas such as cardiovascular, central nervous system, endocrinological, gastrointestinal, anti-infectives, and oncology medicines, supporting multiple new drug launches. Slayback also holds a GSA contract, indicating its capabilities in government-related pharmaceutical supply.